scholarly journals Screening for Severe Combined Immunodeficiency on the Ohio Newborn Screen Using TREC Analysis: Experience from the First Four Years

2018 ◽  
Vol 141 (2) ◽  
pp. AB27 ◽  
Author(s):  
David E. Tapke ◽  
Benjamin Prince ◽  
Peter Mustillo ◽  
Sherman Alter ◽  
Rosemary Hage ◽  
...  
Keyword(s):  
Severe Combined Immunodeficiency ◽  
Combined Immunodeficiency ◽  
Newborn Screen

scholarly journals Newborn Screening: Current Status in Alberta, Canada

2019 ◽  
Vol 5 (4) ◽  
pp. 37 ◽  
Author(s):  
De Souza ◽  
Wolan ◽  
Battochio ◽  
Christian ◽  
Hume ◽  
...  
Keyword(s):  
Newborn Screening ◽  
Severe Combined Immunodeficiency ◽  
Standard Of Care ◽  
Current Status ◽  
Combined Immunodeficiency ◽  
Cell Disease ◽  
Continuous Quality ◽  
Screen Result ◽  
Newborn Screen ◽  
Metabolic Screening

Newborn screening (NBS) in Alberta is delivered by a number of government and health service entities who work together to provide newborn screening to infants born in Alberta, the Northwest Territories, and the Kitikmeot region of the Nunavut territory. The Alberta panel screens for 21 disorders (16 metabolic, two endocrine, cystic fibrosis, severe combined immunodeficiency, and sickle cell disease). NBS is a standard of care, but is not mandatory. NBS performance is monitored by the Alberta Newborn Metabolic Screening (NMS) Program and NMS Laboratory, who strive for continuous quality improvement. Performance analysis found that over 99% of registered infants in Alberta received a newborn screen and over 98% of these infants received a screen result within 10 days of age.

Sign in / Sign up

Export Citation Format

Share Document